Hot off the press! The highly anticipated updated EU guidelines for hidradenitis suppurativa (HS) have been published, marking a major step forward for HS care. It’s been nearly a decade since the last update, and this 2024 edition brings important advancements and fresh perspectives on treatment strategies. The guidelines reflect the latest research, highlight innovative therapies, and refine the assessment of HS phenotypes to help healthcare professionals make appropriate treatment decisions to optimise outcomes for people with HS. See the updated guidelines here and stay at the forefront of HS care https://lnkd.in/eW_EwFz3
About us
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology
- Website
-
http://www.ucb.com
External link for UCB
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Brussels
- Type
- Privately Held
- Founded
- 1928
- Specialties
- Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Locations
Employees at UCB
Updates
-
🚀 Celebrating innovation at UCB’s 2024 Startup Program Pitch Day! 🌍 Last week, we celebrated our annual Pitch Day, showcasing the journey and achievements of four digital health startups that have been collaborating with UCB mentors to transform patient care. Join us in celebrating the groundbreaking work of Allos, Skin Check, Proton Health (Techstars 2024) and Dermus – each pushing boundaries in epilepsy, dermatology, and beyond. The live event was held in Brussels and Atlanta and had a virtual global audience. Pitch Day is a truly collaborative, international celebration of healthcare innovation. We’d like to especially thank The Bakery and our panel of jurors – Emmanuel Caeymaex, Taco van Tiel, Erik Janssen, Catherine RIVES, Trishna Bharadia, BA(hons), MFPM(Hon), Alisa Maria Matei, Kamal Jethwani Curious to learn more and reveal the winners of our Jury Award and Audience Award? Dive into our article for all the details! 👉 https://lnkd.in/dx9Zk-Yv #DigitalHealth #HealthcareInnovation #PitchDay2024 #UCB #Startups #PatientCare
-
Take your expertise to new levels at our state-of-the art Belgium Biomanufacturing Operations Center in Braine-l’Alleud, Belgium. We believe everyone deserves to live the best life they can. This ambition fuels our purpose – creating value in the lives of people living with severe diseases. Opening our new biomanufacturing facility in Braine-l’Alleud means we can expand our capabilities, producing advanced medicines that make real improvements for patients. We’re hiring: Production Technicians/Specialists, Quality Specialists, Compliance Specialists & Process Engineers. Join us. Advance Life. Learn more about our Engineering and Manufacturing jobs at UCB https://lnkd.in/djW27gMD #PharmaJobs #Biomanufacturing #TeamUCB
-
As we close out 2024, we asked our UCB team to describe their year in one word. From empathy and collaboration to innovation and reinvention, these words capture the commitment, passion, and transformative growth that define our mission to improve patients’ lives. Hear how our team reflects on the past year with #TeamUCB Gabriele Bruttini Joshua Kim Thyago Ohana Antonia Küpping Mathilde DREAN Devendra Kalkar Celia Lopez Aguado Alexandre MARTRA #MakeYourMarkForPatients #PharmaJobs https://lnkd.in/dHkyid5y
-
We are proud to be a key partner of the newly launched IHI AutoPiX project, a collaborative effort supported by the Innovative Health Initiative (IHI). Together with European research partners, pharmaceutical companies, small and medium-sized enterprises, and patient organizations, we are working to advance imaging in major rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. These diseases affect millions of people across Europe and present significant challenges in diagnosis, treatment decisions, and monitoring. The potential of medical imaging in routine clinical care is currently underutilized. The AutoPiX consortium aims to overcome these hurdles by leveraging the power of AI-driven imaging biomarkers. This technology can make clinical imaging more accessible, efficient, and interpretable—not just for scientists and clinicians, but more importantly for people living with rheumatic disease. Prof. Xenofon Baraliakos and UCB’s Joeri Nicolaes are co-leading on a subproject specifically related to imaging in axial spondyloarthritis. We are committed to improving lives and are excited to contribute to solutions that not only bring clarity to complex diseases but also foster personalized, precise, and sustainable care for patients. Learn more about how AutoPiX is using cutting-edge technology to transform rheumatology care and enhance outcomes for individuals living with chronic illness. #Partnership #AutoPixProject #Innovation #Rheumatology #PatientCare #IHI #Imaging #AI
First press release of AutoPix is out!
-
When your child receives a diagnosis of a rare and life-limiting condition with no known cure, it can be devastating. But it can also be a source of strength and resilience. Discover how one family found hope and community amidst the uncertainty. Read the full story in the latest edition of RARE Revolution here. https://lnkd.in/dewV2v4f #RareDiseases #MitochondrialDisease RARE Revolution Magazine
-
-
We are acutely aware of the ongoing unmet needs of the #epilepsy community, especially for those who continue to experience uncontrolled seizures. If seizures do not self-terminate, they can progress to a prolonged state with potentially life-threatening consequences. Our study presented at American Epilepsy Society Annual Meeting found that people who experience prolonged seizures are 13.5 times more likely to have a seizure emergency. Click here to find out more https://lnkd.in/eR5kbeRM #AES2024
-
-
Epilepsy is about more than just seizures. There are many non-seizure symptoms that have a big impact on patient and caregiver quality of life such as cognitive impairments, developmental delays, psychiatric condition and sleep disturbances. Click here to find out about the future of #epilepsy and how we’re applying our heritage to drive advancements in care beyond seizure control. https://lnkd.in/ekZiW8br #AES2024 American Epilepsy Society
-
We’re proud to be the 2024 Lead Sponsor of Diversity, Equity, and Inclusion events at this year’s American Epilepsy Society Annual Meeting to support efforts toward achieving more equitable #epilepsy care. #AES2024